SCHEMBL7014342

SCHEMBL7014342

CS(=O)(=O)Nc1ccc(C(=O)NCC(C(=O)N(Cc2ccccc2)C2(C#N)CCNC2)C2CCCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.41
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
ADRB1 P08588 4/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
MEN1 O00255 3/20 0.35
ADRB2 P07550 2/20 0.35
ADRB3 P13945 2/20 0.35
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
MMP13 P45452 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
SLC6A3 Q01959 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419141 0.88 AGER (0.39) PRMT5
SCHEMBL7414878 0.85 BACE1 (0.41) CTSSKMT2AALDH1A1SMN1; SMN2PRMT5
SCHEMBL7014338 0.85 CTSS (0.44) CTSSKMT2AALDH1A1ADRB1
SCHEMBL7417235 0.83 L3MBTL1 (0.35) KMT2AALDH1A1KDM4ESMN1; SMN2MEN1
SCHEMBL7422438 0.82 PKM (0.42) CTSSKMT2AALDH1A1MEN1PKM
SCHEMBL7420982 0.80 CTSL (0.36) CTSSALDH1A1ADRB1KDM4EEPHX2
SCHEMBL7413191 0.79 CTSS (0.37) CTSSALDH1A1KDM4EEPHX2MMP13
SCHEMBL7420985 0.79 ALDH1A1 (0.43) KMT2AALDH1A1ADRB1KDM4ESMN1; SMN2
SCHEMBL7413188 0.77 CTSS (0.39) CTSSALDH1A1KDM4ESMN1; SMN2MMP13
SCHEMBL6371524 0.74 L3MBTL1 (0.40) CTSSKMT2AALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003529546-A 2003-10-07 JP claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP claimed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed